[![Artis BioSolutions](https://blog.artisbiosolutions.com/hubfs/logo_artis_landscape%202.svg)](https://artisbiosolutions.com) - [Home](https://artisbiosolutions.com) - [Contact](https://artisbiosolutions.com/contact) # Artis Insights [All](https://blog.artisbiosolutions.com) [Synthetic DNA](https://blog.artisbiosolutions.com/tag/synthetic-dna) [Thought Leadership](https://blog.artisbiosolutions.com/tag/thought-leadership) [mRNA](https://blog.artisbiosolutions.com/tag/mrna) [Fidelity](https://blog.artisbiosolutions.com/tag/fidelity) [GMP Manufaturing](https://blog.artisbiosolutions.com/tag/gmp-manufaturing) [Pandemic Preparedness](https://blog.artisbiosolutions.com/tag/pandemic-preparedness) [CDMO](https://blog.artisbiosolutions.com/tag/cdmo) [CQA](https://blog.artisbiosolutions.com/tag/cqa) [CMC in Advanced Therapies](https://blog.artisbiosolutions.com/tag/cmc-in-advanced-therapies) [AAV](https://blog.artisbiosolutions.com/tag/aav) [Viral Vectors](https://blog.artisbiosolutions.com/tag/viral-vectors) [CAR-T](https://blog.artisbiosolutions.com/tag/car-t) [GMP](https://blog.artisbiosolutions.com/tag/gmp) Featured Post [Synthetic DNA](https://blog.artisbiosolutions.com/tag/synthetic-dna) [Thought Leadership](https://blog.artisbiosolutions.com/tag/thought-leadership) [mRNA](https://blog.artisbiosolutions.com/tag/mrna) ## [Personalized Cancer Vaccines: The Science Is Ready. Is the Manufacturing?](https://blog.artisbiosolutions.com/personalized-cancer-vaccines-the-science-is-ready.-is-the-manufacturing) ![Kate E. Broderick Ph.D](https://blog.artisbiosolutions.com/hubfs/1705601848264%20(2).jpg) Kate E. Broderick Ph.D  ·  September 09, 2026 Merck and Moderna have reported positive Phase 3 data. The vaccine, when tested with an existing immunotherapy, significantly slowed the return of melanoma and its spread to other... [Read More →](https://blog.artisbiosolutions.com/personalized-cancer-vaccines-the-science-is-ready.-is-the-manufacturing) [Synthetic DNA](https://blog.artisbiosolutions.com/tag/synthetic-dna) [Fidelity](https://blog.artisbiosolutions.com/tag/fidelity) [Thought Leadership](https://blog.artisbiosolutions.com/tag/thought-leadership) ## [The Plasmid Bottleneck Is Not New. It Is Just Finally Solvable.](https://blog.artisbiosolutions.com/the-plasmid-bottleneck-is-not-new.-it-is-just-finally-solvable) Kate E. Broderick Ph.D August 28, 2026 For as long as nucleic acid medicine has existed, developers have structured their programs around a bottleneck that everyone in... [Read more →](https://blog.artisbiosolutions.com/the-plasmid-bottleneck-is-not-new.-it-is-just-finally-solvable) [GMP Manufaturing](https://blog.artisbiosolutions.com/tag/gmp-manufaturing) [Synthetic DNA](https://blog.artisbiosolutions.com/tag/synthetic-dna) [Pandemic Preparedness](https://blog.artisbiosolutions.com/tag/pandemic-preparedness) ## [Engineering the Next Era of Medicine: Manufacturing Readiness as a Competitive Advantage](https://blog.artisbiosolutions.com/engineering-the-next-era-of-medicine-manufacturing-readiness-as-a-competitive-advantage) Artis BioSolutions August 26, 2026 Kate Broderick, PhD, Chief Scientific and Innovation Officer at Artis BioSolutions, joined a TechCon panel on what the next era... [Read more →](https://blog.artisbiosolutions.com/engineering-the-next-era-of-medicine-manufacturing-readiness-as-a-competitive-advantage) [CDMO](https://blog.artisbiosolutions.com/tag/cdmo) ## [From Evaluation to Decision: A Practical Framework for Choosing the Right CDMO](https://blog.artisbiosolutions.com/from-evaluation-to-decision-a-practical-framework-for-choosing-the-right-cdmo) Artis BioSolutions August 12, 2026 Over the four posts in this series, we have built a complete framework for evaluating a CDMO for advanced therapy development. We... [Read more →](https://blog.artisbiosolutions.com/from-evaluation-to-decision-a-practical-framework-for-choosing-the-right-cdmo) [CDMO](https://blog.artisbiosolutions.com/tag/cdmo) [CQA](https://blog.artisbiosolutions.com/tag/cqa) ## [Partnership Model and the Questions That Reveal the Most: How to Tell Whether a CDMO is Actually the Right Fit](https://blog.artisbiosolutions.com/partnership-model-and-the-questions-that-reveal-the-most-how-to-tell-whether-a-cdmo-is-actually-the-right-fit) Landmark Bio Team July 20, 2026 [In the first three posts in this series](https://blog.artisbiosolutions.com/process-philosophy-materials-strategy-and-facility-readiness-the-operational-foundations-of-a-strong-cdmo-partnership), we covered the manufacturing landscape for advanced therapies, the importance of... [Read more →](https://blog.artisbiosolutions.com/partnership-model-and-the-questions-that-reveal-the-most-how-to-tell-whether-a-cdmo-is-actually-the-right-fit) [CDMO](https://blog.artisbiosolutions.com/tag/cdmo) ## [Process Philosophy, Materials Strategy, and Facility Readiness: The Operational Foundations of a Strong CDMO Partnership](https://blog.artisbiosolutions.com/process-philosophy-materials-strategy-and-facility-readiness-the-operational-foundations-of-a-strong-cdmo-partnership) Landmark Bio Team July 14, 2026 [In the previous post](https://blog.artisbiosolutions.com/modality-expertise-and-development-integration-why-direct-experience-with-your-biology-matters-most), we covered the two structural criteria that most reliably distinguish a translational development partner... [Read more →](https://blog.artisbiosolutions.com/process-philosophy-materials-strategy-and-facility-readiness-the-operational-foundations-of-a-strong-cdmo-partnership) [CMC in Advanced Therapies](https://blog.artisbiosolutions.com/tag/cmc-in-advanced-therapies) [CDMO](https://blog.artisbiosolutions.com/tag/cdmo) ## [Modality Expertise and Development Integration: Why Direct Experience with Your Biology Matters Most](https://blog.artisbiosolutions.com/modality-expertise-and-development-integration-why-direct-experience-with-your-biology-matters-most) Landmark Bio Team July 06, 2026 In the first post in this series, we looked at the manufacturing landscape for advanced therapies and what the FDA data tells us... [Read more →](https://blog.artisbiosolutions.com/modality-expertise-and-development-integration-why-direct-experience-with-your-biology-matters-most) [Synthetic DNA](https://blog.artisbiosolutions.com/tag/synthetic-dna) [AAV](https://blog.artisbiosolutions.com/tag/aav) ## [One Roof, Two Capabilities: Why Synthetic DNA + AAV Manufacturing Belongs Together](https://blog.artisbiosolutions.com/one-roof-two-capabilities-why-synthetic-dna-aav-manufacturing-belongs-together) Landmark Bio Team June 18, 2026 AAV is one of the most widely used delivery platforms in gene therapy, supporting approved treatments for inherited retinal... [Read more →](https://blog.artisbiosolutions.com/one-roof-two-capabilities-why-synthetic-dna-aav-manufacturing-belongs-together) [Viral Vectors](https://blog.artisbiosolutions.com/tag/viral-vectors) [CAR-T](https://blog.artisbiosolutions.com/tag/car-t) ## [From Bespoke to Off-the-Shelf: The Manufacturing Reckoning Behind CAR-T’s Hottest Race](https://blog.artisbiosolutions.com/from-bespoke-to-off-the-shelf-the-manufacturing-reckoning-behind-car-ts-hottest-race) Amalia Soenens & Lindsey Wolf May 28, 2026 Last November we published [POSTmark CAR-T: Delivering Therapies Without Delay](https://blog.artisbiosolutions.com/postmark-car-t-delivering-therapies-without-delay), arguing that manufacturing continuity—not... [Read more →](https://blog.artisbiosolutions.com/from-bespoke-to-off-the-shelf-the-manufacturing-reckoning-behind-car-ts-hottest-race) [GMP](https://blog.artisbiosolutions.com/tag/gmp) [CDMO](https://blog.artisbiosolutions.com/tag/cdmo) [CQA](https://blog.artisbiosolutions.com/tag/cqa) ## [Tech-Transfer and Manufacturing for Scaling Biotech](https://blog.artisbiosolutions.com/tech-transfer-and-manufacturing-for-scaling-biotech) Landmark Bio Team April 27, 2026 At Advanced Therapies Week 2026, our [Chief Technology Officer, Gregg Nyberg](https://www.linkedin.com/in/gregg-nyberg/), joined a panel of industry leaders to discuss how... [Read more →](https://blog.artisbiosolutions.com/tech-transfer-and-manufacturing-for-scaling-biotech) #### [SERVICES](https://artisbiosolutions.com/services) - [Process Development](https://artisbiosolutions.com/services/process-development) - [Analytical Development](https://artisbiosolutions.com/services/analytical-development) - [GMP Manufacturing](https://artisbiosolutions.com/services/gmp-manufacturing) - [CMC Strategy](https://artisbiosolutions.com/services/cmc-strategy) [![LinkedIn](https://blog.artisbiosolutions.com/hubfs/LinkedIn.svg)](https://www.linkedin.com/company/artisbiosolutions/) #### [SYNTHETIC DNA](https://artisbiosolutions.com/synthetic-dna) - [Why Cell-Free DNA](https://artisbiosolutions.com/synthetic-dna/why-cell-free-dna) - [oDNA Platform](https://artisbiosolutions.com/synthetic-dna/odna-platform) #### [THERAPEUTIC MODALITIES](https://artisbiosolutions.com/therapeutic-modalities) - [Cell Therapy](https://artisbiosolutions.com/therapeutic-modalities/cell-therapy) - [Viral Vectors](https://artisbiosolutions.com/therapeutic-modalities/viral-vectors) - [Non-Viral Delivery](https://artisbiosolutions.com/therapeutic-modalities/non-viral-delivery) #### [COMPANY](https://artisbiosolutions.com/company/about) - [About](https://artisbiosolutions.com/company/about) - [Facilities](https://artisbiosolutions.com/company/facilities) - [Partnering](https://artisbiosolutions.com/company/partnering) - [Resources](https://artisbiosolutions.com/company/resources) - [Contact](https://artisbiosolutions.com/contact) [![Artis BioSolutions](https://blog.artisbiosolutions.com/hubfs/logo_artis_landscape%202.svg)](https://artisbiosolutions.com) © 2026 Artis BioSolutions. All rights reserved. [Privacy Policy](https://artisbiosolutions.com/privacy-policy) [Cookies Settings](https://artisbiosolutions.com/cookies)